According to the organization, the well-being of oral health professionals who provide oral health care and educate future dental professionals is a top priority for ADEA, which believes that the oral health community must continue to set a positive example when it comes to vaccinations.
ADEA's statement comes in the wake of an Executive Order requiring COVID-19 vaccinations for federal employees.
Additionally, a Joint Statement issued by the American Public Health Association and more than four dozen other health care organizations calls for all health care and long-term care employers to require their employees to receive the COVID-19 vaccine.
The Centers for Disease Control and Prevention has more detail on the COVID-19 vaccines and their effectiveness in reducing transmission of the coronavirus.
The American Dental Education Association is The Voice of Dental Education.
Its mission is to lead and support the health professions community in preparing future-ready oral health professionals.
ADEA members include all 78 US and Canadian dental schools, more than 800 allied and advanced dental education programs, more than 50 corporations and approximately 18,000 individuals.
EpiVax introduces AI-enhanced models for immunogenicity prediction
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070